https://www.selleckchem.com/pr....oducts/gsk1120212-jt
[This corrects the article DOI 10.3389/fonc.2020.573295.].[This corrects the article .]. Although the performance of adjuvant chemoradiotherapy (ACRT) for resected gallbladder cancer may improve the survival for certain patients, its impact on the survival in early-stage resected gallbladder adenocarcinoma (GBAC) patients remains underexplored. This study aimed to determine the ACRT effects on the survival of early-stage resected GBAC patients. Patients with early-stage resected GBAC diagnosed between 2010 and 2016 were sel
Like
Comment
Share
